These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6039768)

  • 1. Clinical evaluation of a new alkylating agent, azetepa, in one hundred and twenty-five cases of malignant tumors.
    Choy DS; Arandia J; Rosenbaum I
    Int J Cancer; 1967 Mar; 2(2):189-93. PubMed ID: 6039768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anticancer chemotherapy with evaluation of combined treatments].
    Saito T
    Poumon Coeur; 1968; 24(1):129-31. PubMed ID: 5652199
    [No Abstract]   [Full Text] [Related]  

  • 3. Intra-articular use of cytostatica. (Thio-Tepa, Azetepa and Osmium acid).
    Langkilde M; Rossel I
    Acta Rheumatol Scand; 1967; 13(2):92-100. PubMed ID: 4961259
    [No Abstract]   [Full Text] [Related]  

  • 4. Azetepa--a new alkylating agent.
    McLean JA
    Isr J Med Sci; 1965 Jul; 1(4):805-7. PubMed ID: 5323047
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I study of ethylbis(2,2-dimethyl-1-aziridinyl) phosphinate (AB-163).
    Wampler GL; Kuperminc M; Regelson W
    Cancer Chemother Pharmacol; 1980; 4(1):49-52. PubMed ID: 7363402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of meturedepa (NSC-51325) in 233 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):667-73. PubMed ID: 4895430
    [No Abstract]   [Full Text] [Related]  

  • 7. AZETEPA (NSC-64826) IN STAGE IV BREAST CANCER.
    FALKSON G; FALKSON HC
    Cancer Chemother Rep; 1964 Dec; 43():19-24. PubMed ID: 14250646
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy of cancer].
    Saito T
    Gan No Rinsho; 1968 Jan; 14(1):71-3. PubMed ID: 5692170
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chromosome aberrations induced by fortrin in human lymphocytes in cultures and in vivo].
    Sinkus AG; Sinkuvene DS
    Tsitologiia; 1976 Sep; 18(9):1115-9. PubMed ID: 1014102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with a new anticancer agent, carbazilquinone (NSC-134679).
    Saito T; Oira S; Wakui A; Yokoyama M; Takahashi H
    Cancer Chemother Rep; 1973; 57(4):447-57. PubMed ID: 4586952
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory lymphoma.
    McLaughlin P; Cabanillas F; Bedikian AY; Bodey GP
    Cancer Treat Rep; 1983 May; 67(5):507-8. PubMed ID: 6850666
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with a new alkylating agent, azetepa, in a variety of solid tumors.
    CHOY DS; STYLIANOU S
    Cancer Chemother Rep; 1962 Oct; 23():47-50. PubMed ID: 14021063
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiation sensitizing agents in clinical radiation and chemotherapy.
    Ambrus JL; Ambrus CM; Bardos TJ; Chmielewicz ZF
    J Med; 1980; 11(1):29-38. PubMed ID: 6156977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of the clinical study of a preparation of diiodobenzotef in malignant tumors].
    Karev NI; Garin AM; Blokhina NG; Pershin MP; Trapeznikova MF
    Klin Med (Mosk); 1975 May; 52(5):50-3. PubMed ID: 1133992
    [No Abstract]   [Full Text] [Related]  

  • 15. Response of human tumours 'in vitro' to CB-1954 (5-aziridinyl-2, 4-dinitrobenzamide).
    Bhat AV; Rao KV; Bapat CV
    Indian J Cancer; 1977 Jun; 14(2):132-5. PubMed ID: 914303
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II evaluation of diaziquone in gastric and pancreatic cancers. A Southeastern Cancer Study Group Trial.
    DeSimone P; Kramer B; Omura GA; Bartolucci AA
    Am J Clin Oncol; 1986 Oct; 9(5):401-2. PubMed ID: 3776902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic leukemia therapy with trenimon].
    Rattka P
    Pol Tyg Lek; 1965 Dec; 20(49):1857-8. PubMed ID: 5867901
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy of malignant tumors. 44].
    Seidenglanz G
    Pharm Prax; 1970; 6():122-38. PubMed ID: 4917035
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biological effects of leakadin].
    Garin AM; Lichinitser MR; Dmitrieva NV; Rubtsov BI; Leneva NV
    Vopr Onkol; 1988; 34(2):192-6. PubMed ID: 2964757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of diaziquone.
    Frytak S; Eagan RT; Ames MM; Creagan ET; Nichols WC
    Cancer Treat Rep; 1984; 68(7-8):975-8. PubMed ID: 6744349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.